Latest Headlines

  1. Roche's First Respiratory Test Powered By TAGS Technology Receives FDA Clearance For SARS-CoV-2, Influenza A, Influenza B And RSV 8/4/2025

    Roche today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the cobas® Respiratory 4-flex.

  2. EVIDENT To Acquire Pramana, Inc 8/4/2025

    Evident announces a definitive agreement to acquire Pramana, Inc., a leading manufacturer of digital pathology solutions.

  3. Agilent Expands The Dako Omnis Family With Three New Models To Meet Evolving Pathology Lab Needs 8/4/2025

    Agilent Technologies Inc. today announced the introduction of its Dako Omnis family of instruments with three new models—Agilent Dako Omnis 110, 165, and 165 Duo—designed to meet the evolving needs of pathology laboratories of all sizes.

  4. Clinisys Acquires Orchard Software 8/1/2025

    Clinisys today announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses.

  5. Innovative Liquid Biopsy Test Uses RNA To Detect Early-Stage Cancer 7/31/2025

    A new liquid biopsy developed by researchers at the University of Chicago is offering a powerful new window into cancer’s earliest stages by flagging subtle shifts in the gut microbiome.

  6. Your Tumor's Best Treatment? A Space-Based Test Could Tell You 7/31/2025

    What if your cancer treatment could be tested in space—before it's ever used on you? A biotech startup is leveraging the unique microgravity environment onboard the International Space Station (ISS) to do just that, using real patient tumors to predict how they'll respond to treatment before a single dose is given.

  7. NeoGenomics Launches PanTracer LBx, Expanding Access To Comprehensive Genomic Profiling With Liquid Biopsy 7/30/2025

    NeoGenomics, Inc., a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of NEO PanTracer LBx, a blood-based comprehensive genomic profiling (CGP) test, expanding the company’s PanTracer portfolio.

  8. Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling 7/30/2025

    Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling.

  9. Labcorp Introduces Test Finder, A First-Of-Its-Kind Generative AI Tool To Simplify Lab Test Search 7/30/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS).

  10. Quansys Biosciences Launches Q-View Imager Plus: Delivering Reproducible, High-Impact ELISA Data With Ease 7/29/2025

    Quansys Biosciences, a leader in multiplex immunoassay technology, today announced the launch of the Q-View Imager Plus, a next-generation imaging device designed to deliver reproducible, high-resolution ELISA results with streamlined workflows.